Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Site-Directed Pegylation at Specific Sites Significantly Prolongs the Half-Life of A1A2A3-VWF By Markedly Attenuating LRP1-Mediated Clearance

Jamie M O'Sullivan, Judicael Fazavana, PhD, Alain Chan, PhD, Niamh Cooke, PhD, Virginie Terraube, Justin Cohen, PhD, Debra D Pittman, MS, Orla Cunningham, PhD, Matthew Lambert, James S O'Donnell, MD PhD

Blood (2018) 132 (Supplement 1): 1165.

https://doi.org/10.1182/blood-2018-99-114966

Published: 2018

Journal Articles

LRP1 Expression in Sickle Cell Disorders: Insights into the Heterogeneity of Monocytic Response to Heme

Leticia Marani, BS, Felipe Vendrame, BS, MSc, Marina Dorigatti Borges, BS, Sara Teresinha Olalla Saad, MD PhD, Fernando Ferreira Costa, MD PhD, Kleber Yotsumoto Fertrin, MD PhD

Blood (2017) 130 (Supplement 1): 3515.

https://doi.org/10.1182/blood.V130.Suppl_1.3515.3515

Published: 2017

Journal Articles

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Qianqian Zhu#, PhD, Li Yan#, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Kenan Onel, MD PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Song Liu, PhD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 518.

https://doi.org/10.1182/blood.V128.22.518.518

Published: 2016

Journal Articles

LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL)

Lorenz Thurner, MD, Sylvia Hartmann, Klaus-Dieter Preuss, PhD, Natalie Fadle, Maria Kemele, Evi Regitz, Christiane Pott, MD PhD, Rainer-Maria Bohle, Martin-Leo Hansmann, Michael Pfreundschuh, MD

Blood (2015) 126 (23): 2685.

https://doi.org/10.1182/blood.V126.23.2685.2685

Published: 2015

Journal Articles

Blockage of Wnt/B-Catenin Signaling By Nanoparticles Reduces Survival and Proliferation of CLL Cells in Vitro

Ida Franiak-Pietryga, PhD, Henryk Maciejewski, PhD, Barbara Ziemba, PhD, Dietmar Appelhans, PhD, Brigitte Voit, Professor, Malgorzata Misiewicz, PhD, Tadeusz Robak, MD Professor, Jacek Trelinski, MD Professor, Maria Bryszewska, Professor, Maciej Borowiec, Professor

Blood (2015) 126 (23): 3699.

https://doi.org/10.1182/blood.V126.23.3699.3699

Published: 2015

Journal Articles

Activated Protein C Cytoprotective Signaling in Endothelial Cells Involves apoER2 and Disabled-1

Ranjeet Kumar Sinha, PhD, Xia Yang, PhD, Laurent O. Mosnier, PhD, John H. Griffin, PhD

Blood (2012) 120 (21): 1102.

https://doi.org/10.1182/blood.V120.21.1102.1102

Published: 2012

Journal Articles

Biological Explanation of Clinically Observed Elevation of TFPI Plasma Levels After Treatment with TFPI-Antagonistic Aptamer BAX 499

Michael Dockal, PhD, Robert Pachlinger, Rudolf Hartmann, PhD, Sabine Knappe, PhD, Benny Sorensen, Wing Yen Wong, Maureen Conlan, Michael Cecerle, Bruce M. Ewenstein, MD PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD

Blood (2012) 120 (21): 1104.

https://doi.org/10.1182/blood.V120.21.1104.1104

Published: 2012

Journal Articles

Pharmacokinetics, Serum Stability and Immunogenicity of A Polypeptide Inhibitor of B2GPI/Antibody Complexes Tested in Mice.

Andrew Porter, Natalia Beglova

Blood (2012) 120 (21): 2205.

https://doi.org/10.1182/blood.V120.21.2205.2205

Published: 2012

Journal Articles

Whole-Genome Sequencing Results From 30 Patients with Waldenstrom's Macroglobulinemia

Zachary Hunter, Lian Xu, Yangsheng Zhou, MD, Guang Yang, PhD, Xia Liu, MD, Yang Cao, MD, Christina Hanzis, Patricia Sheehy, NP, Robert Manning, Christopher J Patterson, Jason M Laramie, PhD, Donald A Skifter, PhD, Stephen E Lincoln, PhD, Steven P Treon, MD, PhD

Blood (2011) 118 (21): 434.

https://doi.org/10.1182/blood.V118.21.434.434

Published: 2011

Journal Articles

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

Zurina Romay-Penabad, Renan Aguilar-Valenzuela, Rolf T. Urbanus, Ronald H. W. M. Derksen, Maarten T. T. Pennings, Elizabeth Papalardo, Tuya Shilagard, Gracie Vargas, Yong Hwang, Philip G. de Groot, Silvia S. Pierangeli

Blood (2011) 117 (4): 1408–1414.

https://doi.org/10.1182/blood-2010-07-299099

Published: 2011

Journal Articles

Antiphospholipid/Anti-β 2 gpi Antibodies Induce Endothelial Cell Activation through Formation of a Multi-Protein Signaling Complex Consisting of Annexin A2, Toll-Like Receptor 4, Calreticulin and Nucleolin

Fabio V Fonseca, Ph.D., Kristi L Allen, Ph.D., Keith R McCrae, M.D.

Blood (2010) 116 (21): 151.

https://doi.org/10.1182/blood.V116.21.151.151

Published: 2010

Journal Articles

Apolipoprotein E Receptor 2′ Mediates Pathogenic Effects of Dimeric β 2 glycoprotein I and of Anti- β 2 glycoprotein I Antibodies in Vivo

Zurina Romay-Penabad, Ph.D., Rolf T Urbanus, MD, Elizabeth Pappalardo, B.S., Yong Hwang, M.D., Ronald H.W.M. Derksen, MD., Tuya Shilagard, Ph.D., Gracie Vargas, Ph.D., Maarten TT Pennings, Ph.D., Philip G De Groot, PhD, Silvia S Pierangeli, Ph.D.

Blood (2008) 112 (11): 408.

https://doi.org/10.1182/blood.V112.11.408.408

Published: 2008

Journal Articles

Identification of a Role for Apolipoprotein E Receptor 2 as a Platelet Receptor for Factor XI

Tara C White, Michelle A Berny, Erik I Tucker, Jiaqing Pang, David Gailani, MD, Rolf T Urbanus, MD, Philip G de Groot, PhD, András Gruber, MD, Owen JT McCarty, PhD

Blood (2008) 112 (11): 3914.

https://doi.org/10.1182/blood.V112.11.3914.3914

Published: 2008

Journal Articles

Activation of the PI3K-Akt Pathway by Activated Protein C Occurs Via a Novel Receptor, Apolipoprotein E Receptor 2 (ApoER2)

Xia V. Yang, PhD, Yajnavalka Banerjee, PhD, Jose A. Fernandez, MD, PhD, Hiroshi Deguchi, MD, PhD, Xiao Xu, Laurent O. Mosnier, PhD, Rolf T Urbanus, MD, Phillip G deGroot, PhD, Tara C White, Owen J.T. McCarty, PhD, John H. Griffin, PhD

Blood (2008) 112 (11): 695.

https://doi.org/10.1182/blood.V112.11.695.695

Published: 2008

Journal Articles

Regulation of tumor necrosis factor receptor-1 and the IKK-NF-κB pathway by LDL receptor–related protein explains the antiinflammatory activity of this receptor

Alban Gaultier, Sanja Arandjelovic, Sherry Niessen, Cheryl D. Overton, MacRae F. Linton, Sergio Fazio, W. Marie Campana, Benjamin F. Cravatt, III, Steven L. Gonias

Blood (2008) 111 (11): 5316–5325.

https://doi.org/10.1182/blood-2007-12-127613

Published: 2008

Journal Articles

Hypolipemiant besides Antileukemic Effect of Imatinib Mesylate (Case Report).

Radu Bucur Gologan, MD, PhD, Gabriela Constantinescu, MD, Daniela Georgescu, MD, Daniela Ostroveanu, MD,PhD, Didona Vasilache, MD, Camelia Dobrea, MD, Daniela Iancu, MD, Viola Popov, MD

Blood (2006) 108 (11): 4832.

https://doi.org/10.1182/blood.V108.11.4832.4832

Published: 2006

Journal Articles

Interaction of beta2-Glycoprotein I with Members of the Low Density Lipoprotein Receptor Family.

Menno van Lummel, Maarten T.T. Pennings, Ronald H.W.M. Derksen, MD, PhD, Erik Westein, Peter J. Lenting, PhD, Philip G. de Groot, PhD

Blood (2005) 106 (11): 2646.

https://doi.org/10.1182/blood.V106.11.2646.2646

Published: 2005

Journal Articles

LDL-receptor–related protein regulates β2-integrin–mediated leukocyte adhesion

Patricia P. E. M. Spijkers, Paula da Costa Martins, Erik Westein, Carl G. Gahmberg, Jaap J. Zwaginga, Peter J. Lenting

Blood (2005) 105 (1): 170–177.

https://doi.org/10.1182/blood-2004-02-0498

Published: 2005

Journal Articles

Identification of Apolipoprotein E Receptor 2′ as the Low-Density Lipoprotein Receptor on Platelets.

Jan-Willem N. Akkerman, PhD, Suzanne J.A. Korporaal, Ingrid A.M. Relou, PhD, Miranda Van Eck, Martineke Bezemer, Gertie Gorter, Theo J.C. Van Berkel, PhD, Johannes Nimf, PhD, Peter J. Lenting, PhD

Blood (2004) 104 (11): 1549.

https://doi.org/10.1182/blood.V104.11.1549.1549

Published: 2004

NARROW

Site-Directed Pegylation at Specific Sites Significantly Prolongs the Half-Life of A1A2A3-VWF By Markedly Attenuating LRP1-Mediated Clearance

LRP1 Expression in Sickle Cell Disorders: Insights into the Heterogeneity of Monocytic Response to Heme

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

LRPAP1 Is a Frequent B-Cell Receptor Antigen in Mantle Cell Lymphoma (MCL)

Blockage of Wnt/B-Catenin Signaling By Nanoparticles Reduces Survival and Proliferation of CLL Cells in Vitro

Activated Protein C Cytoprotective Signaling in Endothelial Cells Involves apoER2 and Disabled-1

Biological Explanation of Clinically Observed Elevation of TFPI Plasma Levels After Treatment with TFPI-Antagonistic Aptamer BAX 499

Pharmacokinetics, Serum Stability and Immunogenicity of A Polypeptide Inhibitor of B2GPI/Antibody Complexes Tested in Mice.

Whole-Genome Sequencing Results From 30 Patients with Waldenstrom's Macroglobulinemia

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

Antiphospholipid/Anti-β 2 gpi Antibodies Induce Endothelial Cell Activation through Formation of a Multi-Protein Signaling Complex Consisting of Annexin A2, Toll-Like Receptor 4, Calreticulin and Nucleolin

Apolipoprotein E Receptor 2′ Mediates Pathogenic Effects of Dimeric β 2 glycoprotein I and of Anti- β 2 glycoprotein I Antibodies in Vivo

Identification of a Role for Apolipoprotein E Receptor 2 as a Platelet Receptor for Factor XI

Activation of the PI3K-Akt Pathway by Activated Protein C Occurs Via a Novel Receptor, Apolipoprotein E Receptor 2 (ApoER2)

Regulation of tumor necrosis factor receptor-1 and the IKK-NF-κB pathway by LDL receptor–related protein explains the antiinflammatory activity of this receptor

Hypolipemiant besides Antileukemic Effect of Imatinib Mesylate (Case Report).

Interaction of beta2-Glycoprotein I with Members of the Low Density Lipoprotein Receptor Family.

LDL-receptor–related protein regulates β2-integrin–mediated leukocyte adhesion

Identification of Apolipoprotein E Receptor 2′ as the Low-Density Lipoprotein Receptor on Platelets.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only